Alamar Biosciences Gross Margin Growth & History (ALMR)
Alamar Biosciences's gross margin was 56.20% for fiscal 2025.
View full Alamar Biosciences company overviewAlamar Biosciences annual gross margin history
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 56.20% | +21.96 pp |
| 2024 | 2024-12-31 | 34.23% | — |
Alamar Biosciences quarterly gross margin
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 60.21% | +7.12 pp |
| Q1 2026 | 2026-03-31 | 55.53% | +6.72 pp |
| Q2 2025 | 2025-06-30 | 53.09% | — |
| Q1 2025 | 2025-03-31 | 48.80% | — |
Alamar Biosciences gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Alamar Biosciences's gross margin increased from 34.23% to 56.20%, a change of +21.96 percentage points. The latest reported quarter, Q2 2026, shows 60.21%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alamar Biosciences source filings ↗